Read more

April 28, 2022
1 min read
Save

Bausch + Lomb announces IPO

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Bausch + Lomb Corp. announced the launch of its initial public offering and roadshow for the IPO.

Bausch Health stated in a press release that it is offering 35 million common shares of its wholly owned subsidiary, Bausch + Lomb, with a 30-day option to purchase up to an additional 5.25 million common shares to cover any over-allotments.

The IPO price is expected to be between $21 and $24 per share, the company stated in the release. Bausch + Lomb has applied to list its common shares on the New York Stock Exchange and the Toronto Stock Exchange under the ticker symbol, BLCO.

Bausch Health said Bausch + Lomb will receive no proceeds from the IPO, but expects that Bausch Health will hold about 90% of the common shares, or 88.5% if the underwriters’ over-allotment option is exercised in full.